# Maria Di Bartolomeo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maria-di-bartolomeo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,472 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 61 |
| i10-index | 211 |
| Last Known Institution | Fondazione IRCCS Istituto Nazionale dei Tumori |
| OpenAlex ID | https://openalex.org/A5075464309 |
| ORCID iD | https://orcid.org/0000-0002-7954-6609 |
| Works | 558 |

## Researcher papers

- [Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma](https://scholariq.org/papers/nivolumab-combination-therapy-in-advanced-esophageal-squamous-cell-carcinoma/)
- [Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-with-cisplatin-and-fluoropyrimidine-as-first-line-therapy-in/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Fondazione IRCCS Istituto Nazionale dei Tumori](https://scholariq.org/institutions/fondazione-irccs-istituto-nazionale-dei-tumori/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.